logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Inapplicable
parent relation
Individuals in focus

Collins, Iain Alistair

    Related profiles found in government register
  • Collins, Iain Alistair
    British born in December 1970

    Resident in United Kingdom

    Registered addresses and corresponding companies
  • Collins, Iain Alistair
    British none born in December 1970

    Resident in United Kingdom

    Registered addresses and corresponding companies
    • 1, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom

      IIF 16
child relation
Offspring entities and appointments
Active 16
  • 1
    ARROW THERAPEUTICS LIMITED
    - now 03542871
    GAC NO.111 LIMITED - 1998-05-01 03061100, 03158354, 03170569... (more)
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (5 parents)
    Officer
    2017-05-31 ~ now
    IIF 4 - Director → ME
  • 2
    ASTRA PHARMACEUTICALS LIMITED
    - now 00098220
    ASTRA CHEMICALS LIMITED - 1979-12-31
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (5 parents)
    Officer
    2017-05-31 ~ now
    IIF 2 - Director → ME
  • 3
    ASTRAPHARM
    00519037
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (5 parents)
    Officer
    2017-05-31 ~ now
    IIF 3 - Director → ME
  • 4
    ASTRAZENECA FINANCE LIMITED
    - now 02761796
    ZENECA FINANCE LIMITED - 2000-08-31
    BIOMONDE LIMITED - 1992-11-19
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (5 parents)
    Officer
    2017-05-31 ~ now
    IIF 1 - Director → ME
  • 5
    ASTRAZENECA INTERMEDIATE HOLDINGS LIMITED
    06442028
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (6 parents, 1 offspring)
    Officer
    2017-05-31 ~ now
    IIF 8 - Director → ME
  • 6
    ASTRAZENECA SWEDEN INVESTMENTS LIMITED
    04726837
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (5 parents)
    Officer
    2017-05-31 ~ now
    IIF 15 - Director → ME
  • 7
    ASTRAZENECA TREASURY LIMITED
    - now 02910116
    ZENCO (NO. 10) LIMITED - 2000-08-31 02908000, 02908089
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (5 parents, 10 offsprings)
    Officer
    2017-05-31 ~ now
    IIF 12 - Director → ME
  • 8
    ASTRAZENECA UK LIMITED
    - now 03674842
    ASTRAZENECA PHARMA LIMITED - 1999-08-03
    ASTRAZENECA LIMITED - 1999-04-05 02723534
    LETTERPLANT LIMITED - 1998-12-16
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (13 parents, 24 offsprings)
    Officer
    2017-05-31 ~ now
    IIF 9 - Director → ME
  • 9
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (5 parents)
    Officer
    2017-05-31 ~ now
    IIF 11 - Director → ME
  • 10
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (5 parents)
    Officer
    2017-05-31 ~ now
    IIF 13 - Director → ME
  • 11
    CAMBRIDGE ANTIBODY TECHNOLOGY GROUP LIMITED
    - now 03234033
    CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC - 2011-09-01
    INTERCEDE 1186 LIMITED - 1996-08-22 01674180, 01678668, 01678669... (more)
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (5 parents, 1 offspring)
    Officer
    2017-05-31 ~ now
    IIF 14 - Director → ME
  • 12
    KUDOS HORSHAM LIMITED
    - now 03504043
    CHEMOVATION LTD. - 2005-01-07 05316858
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (5 parents)
    Officer
    2017-05-31 ~ now
    IIF 6 - Director → ME
  • 13
    KUDOS PHARMACEUTICALS LIMITED
    03479984
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (9 parents, 1 offspring)
    Officer
    2017-05-31 ~ now
    IIF 7 - Director → ME
  • 14
    MEDIMMUNE LIMITED
    - now 02451177
    CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED - 2007-10-29
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Active Corporate (14 parents)
    Officer
    2017-05-31 ~ now
    IIF 5 - Director → ME
  • 15
    MEDIMMUNE U.K. LIMITED
    - now 03854275
    AVIRON UK LIMITED - 2002-08-05
    LAW 2013 LIMITED - 1999-10-15 02106272, 02237808, 02237994... (more)
    Plot 6 Renaissance Way, Boulevard Industry Park, Speke, Liverpool
    Active Corporate (5 parents)
    Officer
    2017-05-31 ~ now
    IIF 10 - Director → ME
  • 16
    MERONEM GROUP LIMITED
    - now 09369712
    AZENCO1 LIMITED - 2015-09-24 09406851, 09679603, 09965954... (more)
    1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom
    Dissolved Corporate (5 parents)
    Officer
    2017-05-31 ~ dissolved
    IIF 16 - Director → ME

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.